Involvement of the MKK6-p38γ cascade in γ-radiation-induced cell cycle arrest

Molecular and Cellular Biology

Volumn 20, Issue 13, 2000, Pages 4543-4552

  Wang, Xiaofei ^a   McGowan, Clare H ^a   Zhao, Ming ^a,d   He, Liusheng ^a   Downey, Jocelyn S ^a   Fearns, Colleen ^a   Wang, Yibin ^b   Huang, Shi ^a   Han, Jiahuai ^a,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATM PROTEIN; CDC25C PROTEIN; CELL CYCLE PROTEIN; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 1; DNA BINDING PROTEIN; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; ISOENZYME; MAP2K1 PROTEIN, HUMAN; MAP2K5 PROTEIN, HUMAN; MAP2K6 PROTEIN, HUMAN; MAP2K7 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PYRIDINE DERIVATIVE; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ARTICLE; CELL CYCLE; DNA DAMAGE; GAMMA RADIATION; HUMAN; HUMAN CELL; MAMMAL CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; CELL CYCLE G2 PHASE; CELL DEATH; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GENETICS; HELA CELL; METABOLISM; PHOSPHORYLATION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FIBROBLASTS; G2 PHASE; GAMMA RAYS; HELA CELLS; HUMANS; IMIDAZOLES; ISOENZYMES; MAP KINASE KINASE 1; MAP KINASE KINASE 5; MAP KINASE KINASE 6; MAP KINASE KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASE 7; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0033625759     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.13.4543-4552.2000     Document Type: Article

References (61)

1. Abbott, D. W., and J. T. Holt. 1999. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J. Biol. Chem. 274:2732-2742.
2. Abrieu, A., D. Fisher, M. N. Simon, M. Doree, and A. Picard. 1997. MAPK inactivation is required for the G2 to M-phase transition of the first mitotic cell cycle. EMBO J. 16:6407-6413.
3. Aldridge, D. R., and I. R. Radford. 1998. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 58:2817-2824.
4. Baldin, V., C. Cans, M. Knibiehler, and B. Ducommun. 1997. Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J. Biol. Chem. 272:32731-32734.
5. Blasina, A., I. V. de Weyer, M. C. Laus, W. H. Luyten, A. E. Parker, and C. H. McGowan. 1999. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol. 9:1-10.
6. Blasina, A., E. S. Paegle, and C. H. McGowan. 1997. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell 8:1013-1023.
7. Blasina, A., B. D. Price, G. A. Turenne, and C. H. McGowan. 1999. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1135-1138.
8. Brown, A. L., C. H. Lee, J. K. Schwarz, N. Mitiku, H. Piwnica-Worms, and J. H. Chung. 1999. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 96:3745-3750.
9. Chaturvedi, P., W. K. Eng, Y. Zhu, M. R. Mattern, R. Mishra, M. R. Hurle, X. Zhang, R. S. Annan, Q. Lu, L. F. Faucette, G. F. Scott, X. Li, S. A. Carr, R. K. Johnson, J. D. Winkler, and B. B. Zhou. 1999. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18:4047-4054.
10. Coleman, T. R., and W. G. Dunphy. 1994. Cdc2 regulatory factors. Curr. Opin. Cell Biol. 6:877-882.
11. Conrad, P. W., R. T. Rust, J. Han, D. E. Millhorn, and D. Beitner-Johnson. 1999. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem. 274:23570-23576.
12. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
13. Derijard, B., J. Raingeaud, T. Barrett, I.-H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
14. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689.
15. Furnari, B., A. Blasina, M. N. Boddy, C. H. McGowan, and P. Russell. 1999. Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. Mol. Biol. Cell 10:833-845.
16. Furnari, B., N. Rhind, and P. Russell. 1997. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277:1495-1497.
17. Goedert, M., A. Cuenda, M. Craxton, R. Jakes, and P. Cohen. 1997. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16:3563-3571.
18. Hain, J., E. Weller, T. Jung, and W. Burkart. 1996. Effects of ionizing- and UV B-radiation on proteins controlling cell cycle progression in human cells: comparison of the MCF-7 adenocarcinoma and the SCL-2 squamous cell carcinoma cell line. Int. J. Radiat. Biol. 70:261-271.
19. Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. T. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299.
20. Han, J., J. D. Lee, P. S. Tobias, and R. J. Ulevitch. 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268:25009-25014.
21. Han, J., J.-D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
22. Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-634.
23. Hasegawa, M., A. Cuenda, M. G. Spillantini, G. M. Thomas, V. Buee-Scherrer, P. Cohen, and M. Goedert. 1999. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. J. Biol. Chem. 274:12626-12631.
24. He, L., J. X. Yu, L. Liu, I. M. Buyse, M. S. Wang, Q. C. Yang, A. Nakagawara, G. M. Brodeur, Y. E. Shi, and S. Huang. 1998. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 58:4238-4244.
25. Huang, S., Y. Jiang, Z. Li, E. Nishida, P. Mathias, S. Lin, R. J. Ulevitch, G. R. Nemerow, and J. Han. 1997. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6:739-749.
26. Jiang, Y., C. Chen, Z. Li, W. Guo, J. A. Gegner, S. Lin, and J. Han. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:17920-17926.
27. Jin, P., Y. Gu, and D. O. Morgan. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134:963-970.
28. Kato, Y., V. Kravchenko, R. Tapping, J. Han, R. Ulevitch, and J. Lee. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:7054-7066.
29. Kato, Y., R. I. Tapping, S. Huang, M. H. Watson, R. J. Ulevitch, and J. D. Lee. 1998. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395:713-716.
30. Kohn, K., J. Jackman, and P. O'Connor. 1994. Cell cycle control and cancer chemotherapy. J. Cell. Biochem. 54:440-452.
31. Lau, C. C., and A. B. Pardee. 1982. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. USA 79:2942-2946.
32. Lavin, M. F., and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:177-202.
33. Lechner, C., M. A. Zahalka, J.-F. Giot, N. P. H. Moler, and A. Ullrich. 1996. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA 93:4355-4359.
34. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, R. J. Heyes, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. Siemens, S. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. Identification and characterization of a novel protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
35. Li, Z., Y. Jiang, R. J. Ulevitch, and J. Han. 1996. The primary structure of p38gamma: a new member of p38 group of MAP kinase. Biochem. Biophys. Res. Commun. 228:334-340.
36. Lock, R. B., and W. E. Ross. 1990. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res. 50:3761-3766.
37. Lopez-Girona, A., B. Furnari, O. Mondesert, and P. Russell. 1999. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397:172-175.
38. Matsuoka, S., M. Huang, and S. J. Elledge. 1998. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893-1897.
39. McGowan, C. H., and P. Russell. 1995. Cell cycle regulation of human WEE1. EMBO J. 14:2166-2175.
40. Mertens, S., M. Craxton, and M. Goedert. 1996. SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett. 383:273-276.
41. Millar, J. B., and P. Russell. 1992. The cdc25 M-phase inducer: an unconventional protein phosphatase. Cell 68:407-410.
42. Molnar, A., A. M. Theodoras, L. I. Zon, and J. M. Kyriakis. 1997. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:13229-13235.
43. Mueller, P. R., T. R. Coleman, A. Kumagai, and W. G. Dunphy. 1995. Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270:86-90.
44. Murakami, H., and H. Okayama. 1995. A kinase from fission yeast responsible for blocking mitosis in S phase. Nature 374:871-819.
45. Nefsky, B., and D. Beach. 1996. Pub1 acts as an E6-AP-like protein ubiquitin ligasse in the degradation of Cdc25. EMBO J. 15:1301-1312.
46. New, L., and J. Han. 1998. The p38 MAP kinase pathway and it function. Trends Cardiovasc. Med. 8:220-228.
47. Norbury, C., J. Blow, and P. Nurse. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321-3329.
48. Nurse, P. 1997. Checkpoint pathways come of age. Cell 91:865-867.
49. O'Connor, P., and K. Kohn. 1992. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin. Cancer Biol. 3:409-416.
50. Ono, K., and J. Han. 2000. The p38 signaling transduction pathway: activation and function. Cell. Signal. 12:1-13.
51. Palmer, A., A. C. Gavin, and A. R. Nebreda. 1998. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. EMBO J. 17: 5037-5047.
52. Peng, C. Y., P. R. Graves, R. S. Thoma, Z. Wu, A. S. Shaw, and H. Piwnica-Worms. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501-1505.
53. Poon, R. Y., M. S. Chau, K. Yamashita, and T. Hunter. 1997. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:5168-5178.
54. Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501.
55. Shafman, T. D., A. Saleem, J. Kyriakis, R. Weichselbaum, S. Kharbanda, and D. W. Kufe. 1995. Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res. 55:3242-3245.
56. Takenaka, K., T. Moriguchi, and E. Nishida. 1998. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 280:599-602.
57. Walworth, N., S. Davey, and D. Beach. 1993. Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363:368-371.
58. Weichselbaum, R. R., M. A. Beckett, W. Dahlberg, and A. Dritschilo. 1988. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. Int. J. Radiat. Oncol. Biol. Phys. 14:907-912.
59. Weichselbaum, R. R., W. Dahlberg, M. Beckett, T. Karrison, D. Miller, J. Clark, and T. J. Ervin. 1986. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc. Natl. Acad. Sci. USA 83:2684-2688.
60. Wright, J. H., E. Munar, D. R. Jameson, P. R. Andreassen, R. L. Margolis, R. Seger, and E. G. Krebs. 1999. Mitogen-activated protein kinase kinase activity is required for the G2/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA 96:11335-11340.
61. Zhao, M., L. New, V. V. Kravchenko, Y. Kato, H. Gram, F. Di Padova, E. N. Olson, R. J. Ulevitch, and J. Han. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21-30.